Enovis Corporation (NYSE:ENOV), a Delaware-incorporated company specializing in orthopedic, prosthetic, and surgical appliances and supplies, has filed a prospectus supplement with the U.S. Securities ...
Assenagon Asset Management S.A. bought a new position in Enovis Co. (NYSE:ENOV – Free Report) during the 4th quarter, ...
WILMINGTON, DE - Enovis (NYSE: ENOV), a prominent medical technology company with a market capitalization of $2.54 billion, has announced the appointment of Davide Visentin as the new President of ...
Enovis (NYSE: ENOV) announced today that it appointed Davide Visentin as the new president of its International Surgical ...
Wilmington, DE, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Enovisâ„¢, a global medical technology innovator headquartered in the United States, announced recently that Davide Visentin will succeed Dr ...
Enovis has named Davide Visentin as its new president of the international surgical business, according to a Jan. 17 report from Mass Device. Mr. Visentin will succeed Benjamin Reinmann, MD, beginning ...
Enovis (ENOV), a global medical technology company, Friday, announced that Davide Visentin will take over as President of Enovis ...
In a report released yesterday, Vik Chopra from Wells Fargo reiterated a Buy rating on Enovis (ENOV – Research Report), with a price target of ...
GET MORE AI-GENERATED SIGNALS: January 21, 2025, 17:54 pm ET, BY THOMAS KEE- Contributor| Editor: Thomas H. Kee Jr. ( Follow on LinkedIn) Check the time stamp on this data. Updated AI-Generated ...
Wilmington, DE, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Enovisâ„¢, a global medical technology innovator headquartered in the United States, announced recently that Davide Visentin will succeed Dr. Benjamin ...